Morie A. Gertz, MD of Mayo Clinic discusses how Ixazomib will change therapeutic algorithms for myeloma at the Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Morie A. Gertz, MD of Mayo Clinic discusses how Ixazomib will change therapeutic algorithms for myeloma at the Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.